Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
NHS Supply Chain seeks to establish a Framework Agreement for the supply of Insulin Pumps, Continuous Glucose Monitoring, Products Contributing to the Delivery of Hybrid Closed Loop Pathways and Associated Products. This includes but not limited to tethered and patch insulin pumps, continuous glucose monitoring devices, products that contribute to the functionality of hybrid closed loop insulin delivery systems, and consumables. Precise quantities are unknown. It is anticipated in the first year that spend will be approximately £ 240,000,000 - £267,000,000 GBP (Excluding VAT), however this is approximate only and may vary depending on requirements of bodies purchasing under the Framework. Estimated total value over the 4 year agreement is approximately £960,000,000 to £1,067,000,000 Excluding VAT. Please note it is expected that the yearly spend for years 2 , 3 and 4 of the Framework Agreement will rise significantly. Following the National Institute for Health and Care Excellence (NICE) Technology Appraisal TA943 Overview | Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes | Guidance | NICE published 19th December 2023 and the NHS England Implementation Plan https://www.england.nhs.uk/long-read/hybrid-closed-loop-technologies-5-yearimplementationstrategy/
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Abbott Laboratories Limited | 00329102 | ~£1,067,000,000 estimated from lot values | LOBBYIST Newmarket Strategy Limited (1 quarter) |
| Advanced Therapeutics (UK) Ltd | 05517697 | ~£1,067,000,000 estimated from lot values | - |
| Air Liquide Healthcare Ltd | 02230411 | ~£1,067,000,000 estimated from lot values | - |
| Dexcom International Ltd | FC035846 | ~£1,067,000,000 estimated from lot values | - |
| Glooko Limited | 09053906 | ~£1,067,000,000 estimated from lot values | - |
| GlucoRx Ltd | 07513682 | ~£1,067,000,000 estimated from lot values | - |
| Insulet International Ltd | 10695788 | ~£1,067,000,000 estimated from lot values | - |
| Medtronic Limited | 01070807 | ~£1,067,000,000 estimated from lot values | LOBBYIST Political Lobbying & Media Relations Limited (7 quarters) |
| Medtrum Ltd | 10208955 | ~£1,067,000,000 estimated from lot values | - |
| Novo Nordisk | 01118740 | ~£1,067,000,000 estimated from lot values | LOBBYIST WA Communications Ltd (7 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (1 quarter) |
| Urathon Europe Limited | 02766713 | ~£1,067,000,000 estimated from lot values | - |
| Ypsomed Ltd | 07132723 | ~£1,067,000,000 estimated from lot values | - |
Government spending data: These suppliers have received £684,947,267 in 12,304 payments (over £25k) from NHS Supply Chain (DHSC-funded), Manchester University NHS Foundation Trust, Department of Health and Social Care, UK Health Security Agency, Plymouth Hospitals NHS Trust and 17 more public bodies (2017-06-30 to 2026-03-31).